Expiry of Novo Nordisk’s UK patent for Saxenda seen as offering a ‘dry run’ for future generic versions of Ozempic
Stay Ahead of the Curve
Get the latest business insights, expert advice, and exclusive content delivered straight to your inbox. Join a community of forward-thinking entrepreneurs who are shaping the future of business.